Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 7;30(1):9.
doi: 10.1186/s40001-024-02237-0.

Whole transcriptome analysis and construction of gene regulatory networks of granulosa cells from patients with polycystic ovary syndrome (PCOS)

Affiliations

Whole transcriptome analysis and construction of gene regulatory networks of granulosa cells from patients with polycystic ovary syndrome (PCOS)

Yuan Yuan et al. Eur J Med Res. .

Abstract

Objective: Polycystic ovary syndrome (PCOS) is a reproductive endocrine disease characterized by reproductive dysfunction and metabolic abnormalities. The purpose of this study was to explore the expression characteristics of coding and non-coding RNAs in granulosa cells of PCOS, and to provide data support for understanding the pathogenesis of PCOS.

Methods: Three patients with PCOS (according to the 2003 Rotterdam diagnostic criteria) and three normal controls were selected. We used the standard long protocol to collect granulosa cells from two groups, who underwent assisted reproduction at the Reproductive Medicine Center of the Affiliated Hospital of Inner Mongolia Medical University, China. We performed whole-transcriptome sequencing using RNA-Seq technology to construct transcriptome patterns of messenger RNAs (mRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs). These patterns were then subjected to in-depth analysis using bioinformatics tools.

Results: We identified a total of 2111 mRNAs and 4328 non-coding RNAs (ncRNAs) in the PCOS group as compared with the control group. Among the ncRNAs, there were 2047 lncRNAs, 892 circRNAs, and 1389 miRNAs. Based on the condition |log2(fold_change) |≥ 1 and a P-value of ≤ 0.05, we obtained 705 differentially expressed genes (DEGs), 204 differentially expressed lncRNAs, 111 differentially expressed circRNAs, and 88 differentially expressed miRNAs. The target genes were mainly enriched in metabolic pathways such as mitogen-activated protein kinase (MAPK), Wnt, transforming growth factor-beta (TGF-β), and the cell cycle. There were three types of circRNAs, among which the number of exon-type circRNAs accounted for more than 90%. Using co-expression network analysis, we identified several important candidate gene mRNAs (VLDLR, PPP2R2B, and MYOCD), lncRNAs (FBXO30, SNHG14, and PVT1), and miRNAs (miRNA-150); these mRNAs and ncRNAs could play a regulatory role in PCOS granulosa cells.

Conclusion: In this study, we discovered significant alterations in mRNAs, lncRNAs, circRNAs, and miRNAs in PCOS granulosa cells, indicating dysregulation in vital pathways. Notably, genes like VLDLR, PPP2R2B, and MYOCD, along with lncRNAs FBXO30, SNHG14, and PVT1, may contribute to PCOS pathology, shedding light on potential therapeutic targets.

Keywords: Granulosa cells; Polycystic ovary syndrome; Whole transcriptome sequencing; ceRNA network.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was conducted with approval from the Ethics Committee of Affiliated Hospital of Inner Mongolia Medical University (Approval No. WZ2023048). This study was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all participants. Consent for publication: All patients signed a document of informed consent. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The mRNA and lncRNA number of granulosa cells were different between PCOS Group and control group
Fig. 2
Fig. 2
The volcano of mRNA and lncRNAs which were significantly differentially expressed between PCOS group and control group (P < 0.05)
Fig. 3
Fig. 3
Heatmaps of mRNA and lncRNAs which were significantly differentially expressed between PCOS group and control group (P < 0.05)
Fig. 4
Fig. 4
GO function classification of differential genes The horizontal axis represents the pathway, and the vertical axis represents the number of enriched genes (P < 0.05)
Fig. 5
Fig. 5
GO function classification of lncRNA target genes. The horizontal axis represents the pathway, and the vertical axis represents the number of enriched genes (P < 0.05)
Fig. 6
Fig. 6
KEGG classification of differential expression target genes. The horizontal axis represents the enrichment index, while the vertical axis represents the enrichment pathway (P < 0.05)
Fig. 7
Fig. 7
Heatmap of the miRNA which were differentially expressed between PCOS group and control group (P < 0.05). The horizontal axis represents the sample, and the vertical axis represents the clustering pattern (unsupervised clustering)
Fig. 8
Fig. 8
lncRNA–miRNA–mRNA network in granulosa cells. Connection represents the strength of the correlation coefficient. (P < 0.05)

Similar articles

Cited by

References

    1. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(10):2447–69. 10.1210/clinem/dgad463. - PMC - PubMed
    1. Yang R, Li Q, Zhou Z, Qian W, Zhang J, Wu Z, Jin L, Wu X, Zhang C, Zheng B, Tan J, Hao G, Li S, Tian T, Hao Y, Zheng D, Wang Y, Norman RJ, Li R, Liu P, Qiao J. Changes in the prevalence of polycystic ovary syndrome in China over the past decade. Lancet Reg Health West Pac. 2022;31(25): 100494. 10.1016/j.lanwpc.2022.100494. - PMC - PubMed
    1. Du C, Zhao J, Liang L. Construction of miRNA and mRNA expression profiles in granulosa cells from patients with polycystic ovary syndrome. Chin J contraception. 2020;40(04):279–86. 10.3760/CMA.J.CN101441-20190529-00216.
    1. Heidarzadehpilehrood R, Pirhoushiaran M, Binti Osman M, Ling KH, Abdul HH. Unveiling key biomarkers and therapeutic drugs in polycystic ovary syndrome (PCOS) through pathway enrichment analysis and hub gene-miRNA networks. Iran J Pharm Res. 2023;22(1): e139985. 10.5812/ijpr-139985. - PMC - PubMed
    1. Heidarzadehpilehrood R, Pirhoushiaran M, Binti Osman M, Abdul Hamid H, Ling KH. Weighted gene co-expression network analysis (WGCNA) discovered novel long non-coding RNAs for polycystic ovary syndrome. Biomedicines. 2023;11(2):518. 10.3390/biomedicines11020518. - PMC - PubMed

LinkOut - more resources